Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 2 (HNRNPA3P2)
- Target
- HNRNPA3P2
- Molecular classification
- Other (pseudogene), (Not a protein-coding gene, not a receptor, enzyme, or other canonical drug target family)
01
Overview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 2 (HNRNPA3P2) is a processed pseudogene in the human genome, derived from the functional HNRNPA3 gene[1][7]. Unlike its parental gene, HNRNPA3P2 does not encode a functional protein and is not involved in known biological processes or diseases as a protein product. Pseudogenes, in general, may have non-coding regulatory roles—such as RNA-based gene regulation—but there are currently no established biological functions or disease associations attributed to HNRNPA3P2 specifically[1][4].
- Other names
- dJ977B1.2HNRPA3PHNRPA3P2HNRNPA3P2
02
Mechanism of action
Not applicable
03
Biological functions
None for the pseudogene itself; pseudogenes generally do not encode functional proteins.Emerging evidence suggests some pseudogenes may have regulatory RNA functions, such as acting as competing endogenous RNAs (ceRNAs), sponging microRNAs, or participating in chromatin organization, but no specific function for HNRNPA3P2 has been documented
04
Disease associations
None established for HNRNPA3P2 directly.Pseudogenes may sometimes be implicated in gene regulation related to disease, but no evidence is reported for this pseudogene
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 2 (HNRNPA3P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 2 (HNRNPA3P2).